CardiAQ Valve Technologies Company Profile

21:36 EDT 23rd September 2017 | BioPortfolio

Privately held CVT, headquartered in Irvine, Calif., has developed a proprietary system for Transcatheter Mitral Valve Implantation (TMVI). Through the combination of a unique anchoring mechanism and a novel delivery catheter, physicians will be able to accurately and securely implant a new mitral valve within a beating heart, thus avoiding open-heart surgery. The CVT procedure is designed to be performed in a cardiac catheterization laboratory similar to angioplasty or stenting, resulting in less trauma to the patient and substantial cost-savings to the healthcare system.

News Articles [720 Associated News Articles listed on BioPortfolio]

FDA Approves New 'Resilient' Inspiris Heart Valve

The valve is currently surgically implanted, but designed with an eye for future valve-in-valve procedures. FDA Approvals

Surgical Pericardial Valve Treats Aortic Valve Disease

A new bioprosthetic valve (BHV) provides innovative features designed to enhance clinical performance during aortic valve replacement.

Edwards Lifesciences' SAPIEN 3 Valve Wins FDA Nod for Aortic, Mitral Valve-In-Valve Procedures

  Life Sciences Jobs   ...

FDA approves new indication for Edwards' Sapien 3 heart valve

Edwards Lifesciences has secured approval from the US Food and Drug Administration (FDA) for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).

FDA Used Real-World Evidence In Heart Valve Approval

RAPS |  The US Food and Drug Administration says it relied on real-world evidence in its decision to expand the use of Edwards Lifesciences' Sapien 3 transcatheter aortic valve replacement to valve-i...

CoreMedic secures capital for heart-valve repair technologies

SHS Gesellschaft fur Beteiligungsmanagement invested an undisclosed amount in CoreMedic, a heart valve-repair startup based i -More- 

Looking to the Future of Mitral Valve Replacement

Is transapical transcatheter mitral valve implantation poised to become an alternative solution for patients with mitral valve disease? European Heart Journal

Two genetic variants in bicuspid aortic valve development

Researchers report a key protein is affected during heart valve formation, in the first genome-wide study of bicuspid aortic valve.

PubMed Articles [1082 Associated PubMed Articles listed on BioPortfolio]

Transcatheter mitral valve replacement with a novel self-expandable prosthesis: single institutional experience procedural outcomes and follow-up.

We report our experience with the CardiAQ prosthetic valve using both transapical and transseptal access. Aim of our study was proving the feasibility, safety and effectiveness of a novel transcathete...

Transcatheter Aortic Valve Replacement for Perceval Sutureless Aortic Valve Failure.

As experience with Perceval aortic prosthesis and valve-in-valve TAVR grows, it will be crucial to meticulously document short- and long-term follow-up for establishment of real-world safety and durab...

Transcatheter Tricuspid Valve-In-Valve Implantation in Patients with Tricuspid Bioprosthetic Valve Degeneration at High Surgical Risk: A Multicenter Case Series.

Transcatheter tricuspid valve-in-valve implantation (TVIV) is an attractive yet under-explored alternative to redo valve surgery.

Aortic sinus flow stasis likely in valve-in-valve transcatheter aortic valve implantation.

Valve-in-valve procedures using transcatheter aortic valves are increasingly performed to treat degenerated bioprosthetic surgical aortic valves because they are less invasive than redo aortic valve r...

Transcatheter Tricuspid Valve-in-Valve Intervention for Degenerative Bioprosthetic Tricuspid Valve Disease.

Isolated reoperative tricuspid valve replacement is one of the highest risk operations classified in the Society of Thoracic Surgeons registry, particularly in the setting of preexisting right ventric...

Clinical Trials [808 Associated Clinical Trials listed on BioPortfolio]

CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study

Clinical study to evaluate the safety and performance of the CardiAQ-Edwards™ Transcatheter Mitral Valve

A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)

The purpose of the study is to evaluate the initial short and long-term safety and performance of the CardiAQ™ Transcatheter Mitral Valve Implantation System using the Transapical Delive...

Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)

The purpose of the study is to generate early US feasibility data of the CardiAQ™ Transcatheter Mitral Valve Implant System. The study will enroll patients with moderate to severe mitra...

Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study

Early feasibility study to evaluate the safety and function of the Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve

Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement

Prospective, two academic center, non-randomized pilot, acute in-patient study correlating pre-operative imaging studies, intra-operative measurements and intra-operative balloon aortic va...

Companies [1276 Associated Companies listed on BioPortfolio]

CardiAQ Valve Technologies, Inc.

Privately held CardiAQ, headquartered in Irvine, Calif., has developed a proprietary Transcatheter Mitral Valve (TMV) Implant that can be delivered through multiple delivery syste...

CardiAQ Valve Technologies Inc.

CardiAQ Valve Technologies

Privately held CVT, headquartered in Irvine, Calif., has developed a proprietary system for Transcatheter Mitral Valve Implantation (TMVI). Through the combination of a unique anc...

Transcatheter Technologies GmbH

Transcatheter Technologies GmbH is a privately held medical device company, founded in January 2009, and headquartered in Regensburg, Germany. The Trinity transapical aortic valve system's valve p...

BioStable Science & Engineering, Inc.

BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to v...

More Information about "CardiAQ Valve Technologies" on BioPortfolio

We have published hundreds of CardiAQ Valve Technologies news stories on BioPortfolio along with dozens of CardiAQ Valve Technologies Clinical Trials and PubMed Articles about CardiAQ Valve Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CardiAQ Valve Technologies Companies in our database. You can also find out about relevant CardiAQ Valve Technologies Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record